Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rostelecom plans to buy a data center for 4,000 racks

6/26/24 RTKM

Shareholders of Sovcombank approved dividends for 2023

6/26/24 SVCB

Shareholders of Stavropolenergosbyt approved dividends for 2023

6/25/24 STSB

KASE asked Moscow Exchange to exit

6/25/24 MOEX

Shareholders of Diod approved dividends for 3 months 2024

6/25/24 DIOD

Shareholders of Renaissance Insurance approved dividends for 2023

6/25/24 RENI

Shareholders of Sollers approved dividends for 2023

6/25/24 SVAV

Delimobile will increase its fleet by 900 Chery cars

6/25/24 DELI

Head of Rusagro acquired 160.4 th. GDRs of the company

6/25/24 AGRO

Henderson's revenue is up 29.8% YTD

6/25/24 HNFG